- IBDEI2L1 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.3,41214,1,4,0)
- ;;=4^E11.39
- ;;^UTILITY(U,$J,358.3,41214,2)
- ;;=^5002643
- ;;^UTILITY(U,$J,358.3,41215,0)
- ;;=E11.41^^152^2030^6
- ;;^UTILITY(U,$J,358.3,41215,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41215,1,3,0)
- ;;=3^DM Type 2 w/ Diab Mononeuropathy
- ;;^UTILITY(U,$J,358.3,41215,1,4,0)
- ;;=4^E11.41
- ;;^UTILITY(U,$J,358.3,41215,2)
- ;;=^5002645
- ;;^UTILITY(U,$J,358.3,41216,0)
- ;;=E11.42^^152^2030^13
- ;;^UTILITY(U,$J,358.3,41216,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41216,1,3,0)
- ;;=3^DM Type 2 w/ Diab Polyneuropathy
- ;;^UTILITY(U,$J,358.3,41216,1,4,0)
- ;;=4^E11.42
- ;;^UTILITY(U,$J,358.3,41216,2)
- ;;=^5002646
- ;;^UTILITY(U,$J,358.3,41217,0)
- ;;=E11.43^^152^2030^2
- ;;^UTILITY(U,$J,358.3,41217,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41217,1,3,0)
- ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
- ;;^UTILITY(U,$J,358.3,41217,1,4,0)
- ;;=4^E11.43
- ;;^UTILITY(U,$J,358.3,41217,2)
- ;;=^5002647
- ;;^UTILITY(U,$J,358.3,41218,0)
- ;;=E11.44^^152^2030^1
- ;;^UTILITY(U,$J,358.3,41218,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41218,1,3,0)
- ;;=3^DM Type 2 w/ Diab Amyotrophy
- ;;^UTILITY(U,$J,358.3,41218,1,4,0)
- ;;=4^E11.44
- ;;^UTILITY(U,$J,358.3,41218,2)
- ;;=^5002648
- ;;^UTILITY(U,$J,358.3,41219,0)
- ;;=E11.49^^152^2030^8
- ;;^UTILITY(U,$J,358.3,41219,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41219,1,3,0)
- ;;=3^DM Type 2 w/ Diab Neurological Compl
- ;;^UTILITY(U,$J,358.3,41219,1,4,0)
- ;;=4^E11.49
- ;;^UTILITY(U,$J,358.3,41219,2)
- ;;=^5002649
- ;;^UTILITY(U,$J,358.3,41220,0)
- ;;=E11.59^^152^2030^25
- ;;^UTILITY(U,$J,358.3,41220,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41220,1,3,0)
- ;;=3^DM Type 2 w/ Oth Circulatory Compl
- ;;^UTILITY(U,$J,358.3,41220,1,4,0)
- ;;=4^E11.59
- ;;^UTILITY(U,$J,358.3,41220,2)
- ;;=^5002652
- ;;^UTILITY(U,$J,358.3,41221,0)
- ;;=E11.610^^152^2030^9
- ;;^UTILITY(U,$J,358.3,41221,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41221,1,3,0)
- ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
- ;;^UTILITY(U,$J,358.3,41221,1,4,0)
- ;;=4^E11.610
- ;;^UTILITY(U,$J,358.3,41221,2)
- ;;=^5002653
- ;;^UTILITY(U,$J,358.3,41222,0)
- ;;=E11.618^^152^2030^26
- ;;^UTILITY(U,$J,358.3,41222,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41222,1,3,0)
- ;;=3^DM Type 2 w/ Oth Diab Arthropathy
- ;;^UTILITY(U,$J,358.3,41222,1,4,0)
- ;;=4^E11.618
- ;;^UTILITY(U,$J,358.3,41222,2)
- ;;=^5002654
- ;;^UTILITY(U,$J,358.3,41223,0)
- ;;=E11.621^^152^2030^16
- ;;^UTILITY(U,$J,358.3,41223,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41223,1,3,0)
- ;;=3^DM Type 2 w/ Foot Ulcer
- ;;^UTILITY(U,$J,358.3,41223,1,4,0)
- ;;=4^E11.621
- ;;^UTILITY(U,$J,358.3,41223,2)
- ;;=^5002656
- ;;^UTILITY(U,$J,358.3,41224,0)
- ;;=E11.622^^152^2030^31
- ;;^UTILITY(U,$J,358.3,41224,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41224,1,3,0)
- ;;=3^DM Type 2 w/ Oth Skin Ulcer
- ;;^UTILITY(U,$J,358.3,41224,1,4,0)
- ;;=4^E11.622
- ;;^UTILITY(U,$J,358.3,41224,2)
- ;;=^5002657
- ;;^UTILITY(U,$J,358.3,41225,0)
- ;;=E11.628^^152^2030^30
- ;;^UTILITY(U,$J,358.3,41225,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41225,1,3,0)
- ;;=3^DM Type 2 w/ Oth Skin Compl
- ;;^UTILITY(U,$J,358.3,41225,1,4,0)
- ;;=4^E11.628
- ;;^UTILITY(U,$J,358.3,41225,2)
- ;;=^5002658
- ;;^UTILITY(U,$J,358.3,41226,0)
- ;;=E11.630^^152^2030^33
- ;;^UTILITY(U,$J,358.3,41226,1,0)
- ;;=^358.31IA^4^2
- ;;^UTILITY(U,$J,358.3,41226,1,3,0)
- ;;=3^DM Type 2 w/ Periodontal Disease
- ;;^UTILITY(U,$J,358.3,41226,1,4,0)
- ;;=4^E11.630
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2L1 3761 printed Feb 18, 2025@23:57:15 Page 2
- IBDEI2L1 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.3)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.3,41214,1,4,0)
- +2 ;;=4^E11.39
- +3 ;;^UTILITY(U,$J,358.3,41214,2)
- +4 ;;=^5002643
- +5 ;;^UTILITY(U,$J,358.3,41215,0)
- +6 ;;=E11.41^^152^2030^6
- +7 ;;^UTILITY(U,$J,358.3,41215,1,0)
- +8 ;;=^358.31IA^4^2
- +9 ;;^UTILITY(U,$J,358.3,41215,1,3,0)
- +10 ;;=3^DM Type 2 w/ Diab Mononeuropathy
- +11 ;;^UTILITY(U,$J,358.3,41215,1,4,0)
- +12 ;;=4^E11.41
- +13 ;;^UTILITY(U,$J,358.3,41215,2)
- +14 ;;=^5002645
- +15 ;;^UTILITY(U,$J,358.3,41216,0)
- +16 ;;=E11.42^^152^2030^13
- +17 ;;^UTILITY(U,$J,358.3,41216,1,0)
- +18 ;;=^358.31IA^4^2
- +19 ;;^UTILITY(U,$J,358.3,41216,1,3,0)
- +20 ;;=3^DM Type 2 w/ Diab Polyneuropathy
- +21 ;;^UTILITY(U,$J,358.3,41216,1,4,0)
- +22 ;;=4^E11.42
- +23 ;;^UTILITY(U,$J,358.3,41216,2)
- +24 ;;=^5002646
- +25 ;;^UTILITY(U,$J,358.3,41217,0)
- +26 ;;=E11.43^^152^2030^2
- +27 ;;^UTILITY(U,$J,358.3,41217,1,0)
- +28 ;;=^358.31IA^4^2
- +29 ;;^UTILITY(U,$J,358.3,41217,1,3,0)
- +30 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
- +31 ;;^UTILITY(U,$J,358.3,41217,1,4,0)
- +32 ;;=4^E11.43
- +33 ;;^UTILITY(U,$J,358.3,41217,2)
- +34 ;;=^5002647
- +35 ;;^UTILITY(U,$J,358.3,41218,0)
- +36 ;;=E11.44^^152^2030^1
- +37 ;;^UTILITY(U,$J,358.3,41218,1,0)
- +38 ;;=^358.31IA^4^2
- +39 ;;^UTILITY(U,$J,358.3,41218,1,3,0)
- +40 ;;=3^DM Type 2 w/ Diab Amyotrophy
- +41 ;;^UTILITY(U,$J,358.3,41218,1,4,0)
- +42 ;;=4^E11.44
- +43 ;;^UTILITY(U,$J,358.3,41218,2)
- +44 ;;=^5002648
- +45 ;;^UTILITY(U,$J,358.3,41219,0)
- +46 ;;=E11.49^^152^2030^8
- +47 ;;^UTILITY(U,$J,358.3,41219,1,0)
- +48 ;;=^358.31IA^4^2
- +49 ;;^UTILITY(U,$J,358.3,41219,1,3,0)
- +50 ;;=3^DM Type 2 w/ Diab Neurological Compl
- +51 ;;^UTILITY(U,$J,358.3,41219,1,4,0)
- +52 ;;=4^E11.49
- +53 ;;^UTILITY(U,$J,358.3,41219,2)
- +54 ;;=^5002649
- +55 ;;^UTILITY(U,$J,358.3,41220,0)
- +56 ;;=E11.59^^152^2030^25
- +57 ;;^UTILITY(U,$J,358.3,41220,1,0)
- +58 ;;=^358.31IA^4^2
- +59 ;;^UTILITY(U,$J,358.3,41220,1,3,0)
- +60 ;;=3^DM Type 2 w/ Oth Circulatory Compl
- +61 ;;^UTILITY(U,$J,358.3,41220,1,4,0)
- +62 ;;=4^E11.59
- +63 ;;^UTILITY(U,$J,358.3,41220,2)
- +64 ;;=^5002652
- +65 ;;^UTILITY(U,$J,358.3,41221,0)
- +66 ;;=E11.610^^152^2030^9
- +67 ;;^UTILITY(U,$J,358.3,41221,1,0)
- +68 ;;=^358.31IA^4^2
- +69 ;;^UTILITY(U,$J,358.3,41221,1,3,0)
- +70 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
- +71 ;;^UTILITY(U,$J,358.3,41221,1,4,0)
- +72 ;;=4^E11.610
- +73 ;;^UTILITY(U,$J,358.3,41221,2)
- +74 ;;=^5002653
- +75 ;;^UTILITY(U,$J,358.3,41222,0)
- +76 ;;=E11.618^^152^2030^26
- +77 ;;^UTILITY(U,$J,358.3,41222,1,0)
- +78 ;;=^358.31IA^4^2
- +79 ;;^UTILITY(U,$J,358.3,41222,1,3,0)
- +80 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
- +81 ;;^UTILITY(U,$J,358.3,41222,1,4,0)
- +82 ;;=4^E11.618
- +83 ;;^UTILITY(U,$J,358.3,41222,2)
- +84 ;;=^5002654
- +85 ;;^UTILITY(U,$J,358.3,41223,0)
- +86 ;;=E11.621^^152^2030^16
- +87 ;;^UTILITY(U,$J,358.3,41223,1,0)
- +88 ;;=^358.31IA^4^2
- +89 ;;^UTILITY(U,$J,358.3,41223,1,3,0)
- +90 ;;=3^DM Type 2 w/ Foot Ulcer
- +91 ;;^UTILITY(U,$J,358.3,41223,1,4,0)
- +92 ;;=4^E11.621
- +93 ;;^UTILITY(U,$J,358.3,41223,2)
- +94 ;;=^5002656
- +95 ;;^UTILITY(U,$J,358.3,41224,0)
- +96 ;;=E11.622^^152^2030^31
- +97 ;;^UTILITY(U,$J,358.3,41224,1,0)
- +98 ;;=^358.31IA^4^2
- +99 ;;^UTILITY(U,$J,358.3,41224,1,3,0)
- +100 ;;=3^DM Type 2 w/ Oth Skin Ulcer
- +101 ;;^UTILITY(U,$J,358.3,41224,1,4,0)
- +102 ;;=4^E11.622
- +103 ;;^UTILITY(U,$J,358.3,41224,2)
- +104 ;;=^5002657
- +105 ;;^UTILITY(U,$J,358.3,41225,0)
- +106 ;;=E11.628^^152^2030^30
- +107 ;;^UTILITY(U,$J,358.3,41225,1,0)
- +108 ;;=^358.31IA^4^2
- +109 ;;^UTILITY(U,$J,358.3,41225,1,3,0)
- +110 ;;=3^DM Type 2 w/ Oth Skin Compl
- +111 ;;^UTILITY(U,$J,358.3,41225,1,4,0)
- +112 ;;=4^E11.628
- +113 ;;^UTILITY(U,$J,358.3,41225,2)
- +114 ;;=^5002658
- +115 ;;^UTILITY(U,$J,358.3,41226,0)
- +116 ;;=E11.630^^152^2030^33
- +117 ;;^UTILITY(U,$J,358.3,41226,1,0)
- +118 ;;=^358.31IA^4^2
- +119 ;;^UTILITY(U,$J,358.3,41226,1,3,0)
- +120 ;;=3^DM Type 2 w/ Periodontal Disease
- +121 ;;^UTILITY(U,$J,358.3,41226,1,4,0)
- +122 ;;=4^E11.630